Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2013
07/11/2013WO2013036031A3 Pharmaceutical composition including a microrna486 expression inhibitor as an active ingredient for preventing and treating neurological disorders
07/11/2013WO2013020136A3 Treatment of traumatic brain injury
07/11/2013WO2013016332A3 Composition and method for treating migraines
07/11/2013WO2012164398A3 Modulation of the ubiquitin-proteasome system (ups)
07/11/2013US20130178631 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors
07/11/2013US20130177647 Methods for manipulating satiety
07/11/2013US20130177646 Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
07/11/2013US20130177631 Method and medicament for inhibiting the expression of a given gene
07/10/2013EP2612865A2 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
07/10/2013EP2612856A2 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
07/10/2013EP2612703A2 Particulate materials
07/10/2013EP2612670A2 Anesthetic association, anesthetic composition, and anesthetic medicament for veterinary use
07/10/2013EP2612668A2 Pharmaceutical composition for the prevention or treatment of degenerative neurological brain disorders
07/10/2013EP2612553A1 Compositions and Methods for Prophylaxis and Treatment of Addictions
07/10/2013EP2611918A1 Mirnas involved in the blood brain barrier function
07/10/2013EP2611810A1 Substituted tetrahydropyrrolopyrazine derivatives
07/10/2013EP2611805A1 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
07/10/2013EP2611788A2 Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
07/10/2013EP2611780A1 Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
07/10/2013EP2611775A1 Agonists of neurotrophin receptors and their use as medicaments
07/10/2013EP2611765A2 Methods for treating neurodegenerative diseases
07/10/2013EP2611759A1 Deuterated analogs of pridopidine useful as dopaminergic stabilizers
07/10/2013EP2611457A2 Compositions and methods for treating friedreich's ataxia with interferon gamma
07/10/2013EP2611444A1 Heterocyclyl compounds as histamine h3 receptor ligands
07/10/2013EP2611440A1 Treatment for cocaine addiction
07/10/2013EP2611298A1 Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mglur5 receptors
07/10/2013CN1990473B Tri-substituted 1H-imidazoles compounds, preparation method and pharmaceutical composition and pharmacy use thereof
07/10/2013CN103201285A Modified relaxin polypeptides and their uses
07/10/2013CN103201270A P2x4 receptor antagonist
07/10/2013CN103201261A Lactam derivatives useful as orexin receptor antagonists
07/10/2013CN103201258A Amyloid binding agents
07/10/2013CN103200952A Treatment of diseases
07/10/2013CN103200949A Composition for treating neurodegenerative disease or neuropathological condition
07/10/2013CN103200940A Composition comprising a serotonin receptor agonist and a diketopiperazine for treating migraines
07/10/2013CN103200936A Novel n-hydroxy-benzamides for the treatment of cancer
07/10/2013CN103193857A Holarrhine alkaloid derivative and application of holarrhine alkaloid derivative
07/10/2013CN103193792A New compound for treating ischemic cardiovascular and cerebrovascular diseases
07/10/2013CN103193789A Optically active butylphthalide open-ring derivative, preparation method and medical application
07/10/2013CN103193788A Lycorine alkaline compound with neuroprotective effect
07/10/2013CN103193787A Lycoris alkali compound having neuroprotective effect and preparation method thereof
07/10/2013CN103193742A Xanthatin derivative and medicine use thereof
07/10/2013CN103193677A Polymorphic form of methocarbamol disodium phosphate and preparation method thereof
07/10/2013CN103193669A nNOS-Capon uncoupling compound, preparation method and application thereof
07/10/2013CN103193668A Chiral indan derivant and preparation method and application thereof
07/10/2013CN103193659A Novel crystal form of (-)-(1R, 2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl) phenol hydrochloride and preparation method thereof
07/10/2013CN103193646A Medicine for treating pain
07/10/2013CN103193645A Medicine for treating cancer pain
07/10/2013CN103193644A Agent for treating pain diseases
07/10/2013CN103193642A Carvacrol derivatives and synthetic method and application thereof
07/10/2013CN103193604A Asarin compound and freeze-dried powder injection thereof
07/10/2013CN103191407A Novel use of pentapeptide and metabolite thereof in preparation of anti-dementia product
07/10/2013CN103191395A Foot soaking powder for preserving and protecting health and preparation method thereof
07/10/2013CN103191382A Medicine for treating Bi syndrome and preparation method thereof
07/10/2013CN103191374A Traditional Chinese medicine composition for treating insomnia and preparation method of oral preparation thereof
07/10/2013CN103191365A Traditional Chinese medicine for treating epilepsy
07/10/2013CN103191296A Enema medicine for treating night crying of infants
07/10/2013CN103191292A Sleep-promoting and brain-nourishing oral liquid and production method thereof, and production line for oral liquid
07/10/2013CN103191261A Chinese medicinal composition for treating nervous necrosis
07/10/2013CN103191198A Rhizoma corydalis extract as well as preparation method and use thereof
07/10/2013CN103191174A Novel use of eucommia ulmoides chemical component as blood vessel protective agent
07/10/2013CN103191168A Method for preparing burdock root granules
07/10/2013CN103191155A Application of mesenchymal stem cells in preparation of multiple sclerosis treatment medicines, and extraction method of mesenchymal stem cells
07/10/2013CN103191153A Muscular amino acid and nucleoside extract and pharmaceutical composition thereof
07/10/2013CN103191142A Baicalin and taurine composition and application thereof in preparation of medicament
07/10/2013CN103191141A Application of 3-methoxyl mangiferin in preparing medicine used for treating post-stroke depression
07/10/2013CN103191118A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
07/10/2013CN103191106A Application of genipin amino acid derivative as NF-kappa B inhibitor
07/10/2013CN103191104A Use of Aphanamixoid A in drug for treating Alzheimer's disease
07/10/2013CN103191094A Carbidopa-levodopa controlled release tablet and preparation method of tablet
07/10/2013CN103191093A Hangover alleviating composition and application thereof
07/10/2013CN103191082A Venlafaxine hydrochloride spansule and preparation method thereof
07/10/2013CN103191080A Acetylcysteine effervescent tablet
07/10/2013CN103191079A Citicoline sodium tablet and preparation method thereof
07/10/2013CN103191052A L-alpha-glycerol phosphorylcholine injection composition and preparation method thereof
07/10/2013CN103191040A Night cream and preparation method thereof
07/10/2013CN102727728B Resurgent traditional Chinese herbal preparation
07/10/2013CN102698094B Medicament for treating female depression
07/10/2013CN102604960B Neurotoxin S10a of South China Sea Conus striatus, coding sequence and application of the neurotoxin
07/10/2013CN102579328B Pharmaceutical composition for injection
07/10/2013CN102579320B Citicoline sodium brain-targeting thermosensitive gel and preparation method thereof
07/10/2013CN102499913B Preparation method for refined and purified paeonol preparation
07/10/2013CN102488872B Medicament for treating crooked mouths and oblique eyes
07/10/2013CN102429964B Medicine composition for preventing cognitive disorder of old people after surgical operation
07/10/2013CN102362755B Medicinal pillow with effect of benefiting intelligence
07/10/2013CN102223883B Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy
07/10/2013CN102212116B Acetylcholine receptor mediated brain-targeted polypeptide and application thereof
07/10/2013CN102112441B Use of indole derivatives as NURR-1 activators for treating parkinson's disease
07/10/2013CN102099354B Azole compound
07/10/2013CN101932585B Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
07/10/2013CN101768080B Medicinal compound and medicinal use thereof
07/10/2013CN101495480B Constrained compounds as cgrp-receptor antagonists
07/10/2013CN101378742B Use of kCNQ-openers in preparing medicine for treating or reducing the symptoms of schizophrenia
07/10/2013CN101346396B G protein coupling acceptor antagonist for preventing and treating alzheimer's disease and use thereof
07/10/2013CN101282957B New pharmaceutical compounds
07/09/2013USRE44354 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
07/09/2013US8481585 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
07/09/2013US8481580 interleukin 1, 12, tumor necrosis factor alpha, and trigger interferon- gamma antagonist; antiinflammatory , antidiabetic agent, autoimmune disorders; active side chain moiety (5-R-hydroxyhexyl) of lisofyllin, greater potency and oral bioavailability than lisofylline
07/09/2013US8481556 Piperidinone carboxamide azaindane CGRP receptor antagonists
07/09/2013US8481548 2-[4-(2-chloro-pyridin-4-ylethynyl)-2-methyl-imidazol-1-yl]-4-trifluoromethyl-pyrimidine; metabotropic glutamate (mGluR5) receptor antagonist; analgesic, neurodegenerative diseases; psychosis, epilepsy, schizophrenia, Alzheimer' disease, cognititve disorders, memory deficits, chronic and acute pain
07/09/2013US8481537 Caspase inhibitors based of pyridazinone scaffold